![Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy - ScienceDirect Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0959804921001696-gr1.jpg)
Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy - ScienceDirect
![Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship | Nature Reviews Clinical Oncology Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41571-023-00776-9/MediaObjects/41571_2023_776_Fig1_HTML.png)
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship | Nature Reviews Clinical Oncology
![Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance | Nature Reviews Clinical Oncology Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance | Nature Reviews Clinical Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41571-019-0218-0/MediaObjects/41571_2019_218_Fig1_HTML.png)
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance | Nature Reviews Clinical Oncology
![X 上的Conquer: the journey informed:「Why Didn't You Mention the Long-Term Side Effects of Cancer Treatment? https://t.co/bCE4WID2Il https://t.co/TanUZHCayH」 / X X 上的Conquer: the journey informed:「Why Didn't You Mention the Long-Term Side Effects of Cancer Treatment? https://t.co/bCE4WID2Il https://t.co/TanUZHCayH」 / X](https://pbs.twimg.com/media/Df6UUEpWAAAOrgw.jpg)